Tyrosine kinase 2 inhibitors in autoimmune diseases
Chethana Ramakrishna(University Hospital Southampton NHS Foundation Trust), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Alice Mason(King's College Hospital)
Cited by 19
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
|Annals of the Rheumatic Diseases|2013|668